<i>In Vivo</i>Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models
Tadashi Ashizawa(Shizuoka Cancer Center), Yasuto Akiyama(Shizuoka Cancer Center)
Cited by 1
Related Papers
Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line
|Cancer Genomics & Proteomics|2017|41
Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line
|International Journal of Oncology|2014|40